EVOKE PHARMA INC's ticker is and the CUSIP is 30049G203. A total of 16 filers reported holding EVOKE PHARMA INC in Q1 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 724,942 | $442,215 | 0.18% |
| AIGH Capital Management LLC | 846,564 | $516,404 | 0.16% |
| Bleichroeder LP | 825,000 | $503,250 | 0.13% |
| Nantahala Capital Management | 675,000 | $411,750 | 0.02% |
| ROYAL BANK OF CANADA | 28 | $0 | 0.00% |
| VANGUARD GROUP INC | 29,851 | $18,209 | 0.00% |
| WELLS FARGO & COMPANY/MN | 66 | $40 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 1,107 | $675 | 0.00% |
| NewEdge Advisors, LLC | 208 | $127 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 27,065 | $16,509 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 10,869 | $6,630 | 0.00% |
| BlackRock Inc. | 1,464 | $893 | 0.00% |
| GOLDMAN SACHS GROUP INC | 13,471 | $8,217 | 0.00% |
| Tower Research Capital LLC (TRC) | 7,405 | $4,517 | 0.00% |
| MORGAN STANLEY | 750 | $458 | 0.00% |
This page lists EVOKE PHARMA INC's shareholders in Q1 2024. To view EVOKE PHARMA INC's shareholder history, click here.